Radiogenomics in Lung Cancer-Linking Imaging Phenotypes to Genetic Profiles [0.03%]
肺癌放射组学研究——影像表型与基因图谱之间的联系
Hiren J Mehta,Michael DiRico,Karthik Vijayan
Hiren J Mehta
Oligometastatic and Oligoprogressive Disease in Lung Cancer: Concepts for Radiologists [0.03%]
寡转移和寡进展在肺癌中的概念——放射科医生应该了解的内容
Palmi Shah,Ramya S Gaddikeri,Maham Jehangir et al.
Palmi Shah et al.
Challenges in Imaging Pulmonary Nodules: Differentiating Benign from Malignant Lesions [0.03%]
肺结节影像诊断的挑战：良性与恶性病变的鉴别诊断
Samuel R Friedlander,Rocio Perez-Johnston,Markus Y Wu
Samuel R Friedlander
Nupur Verma,Matheus Zanon,Giovanni Torri et al.
Nupur Verma et al.
Letter from the Guest Editor: State of the art and future trends in thoracic oncologic Imaging [0.03%]
客座主编来信：胸部肿瘤影像学的研究进展与未来趋势
Tan Lucien Mohammed
Tan Lucien Mohammed
Rethinking Lung Cancer Imaging: A Radiologist's Role in an Evolving Landscape [0.03%]
重新思考肺癌影像学：放射科医生在不断变化的环境中的角色
Prachi P Agarwal
Prachi P Agarwal
Incoming novel radiotracer development: Fibroblast activation protein inhibitors for cancer diagnosis and treatment [0.03%]
新型放射示踪剂的开发在癌症诊断和治疗中的纤维活化蛋白抑制剂的研究进展
Lakshmi Madhusoodanan,Benjamin L Viglianti,Peter J H Scott
Lakshmi Madhusoodanan
Lutetium-177 Theranostics and Dosimetry for Neuroendocrine Neoplasms and Prostate Cancer [0.03%]
镥-177 在神经内分泌肿瘤和前列腺癌诊疗中的应用及剂量学研究
Ka Kit Wong,Eric Hu,Azadeh Akhavanallaf et al.
Ka Kit Wong et al.
PET Beyond FDG: New Era of Oncologic Molecular Targets Using Positron-Emitting Radiotracers [0.03%]
超越FDG的正电子发射放射示踪剂在肿瘤分子靶点中的新应用
Alex Heglin,Bradley Girod,Asha Kandathil
Alex Heglin
What's New in FDG-PET? Recent Advances in Imaging Hospitalized Patients and Infectious/Inflammatory Conditions [0.03%]
FDG-PET的新进展——近期住院患者及感染/炎症状况影像学的进展
Molly E Roseland,Michael C Huarng
Molly E Roseland
Despite growing clinical interest in targeted PET tracers, FDG remains a stalwart in PET imaging due to its widespread availability and applicability. Recent data support expanded clinical indications for FDG-PET in the evaluation of acutel...